Amway’s 1H17 revenue declined 14.9% YTD to RM489m due to high base effect in 1H16 resulting from i) strong buy up in 1H16 ahead of price hikes in Feb and Apr 2016, ii) AM40 National Convention Expo sales in April 2016 and iii) higher ABO momentum towards 40th Anniversary sales and marketing programmes. However, earnings came in flat as revenue decline was partially offset by lower provisions for sales incentives, lower operating expenses and lower effective tax rate.
2Q17 earnings grew RM14.8m (+139%) due to lower provision for sales incentives and lower operating expenses. These partially offset the lower sales (-6.3% yoy) and higher import costs (primarily due to weaker ringgit and higher product cost)
Earnings increased 56.3% qoq on the back of higher sales of RM252m (+6.3%) and lower operating expenses (-2.1 ppts).
We believe outlook remains challenging due to softer domestic economy. As such, Amway has embarked on cost rationalisation and introducing more products to boost earnings. It also rolled out a mobile app for ABOs to reduce turnaround between orders and deliveries as well as enlarge ABO base.
A second interim dividend of 5 sen was declared, lifting 1H17 dividend to 10sen (1H16: 10sen). We expect full year DPS of 280sen, translating into divided yield of 3.3%.
We upgrade to Hold with an unchanged DCF-derived TP of RM6.95 (WACC of 7.5%). We note that value is slowly emerging (after share price retracement) with dividend yields now over 4%. Nevertheless, we believe earnings outlook remains challenging.
Source: BIMB Securities Research - 24 Aug 2017
Chart | Stock Name | Last | Change | Volume |
---|
Created by kltrader | Nov 12, 2024
Created by kltrader | Nov 11, 2024
Created by kltrader | Nov 11, 2024
Created by kltrader | Nov 11, 2024